These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11747720)

  • 21. Transfusion-related transmission of yellow fever vaccine virus--California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(2):34-7. PubMed ID: 20094025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow fever vaccine-associated adverse events following extensive immunization in Argentina.
    Biscayart C; Carrega ME; Sagradini S; Gentile A; Stecher D; Orduna T; Bentancourt S; Jiménez SG; Flynn LP; Arce GP; Uboldi MA; Bugna L; Morales MA; Digilio C; Fabbri C; Enría D; Diosque M; Vizzotti C
    Vaccine; 2014 Mar; 32(11):1266-72. PubMed ID: 24456625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Yellow fever vaccination in non-immunocompetent patients].
    Bruyand M; Receveur MC; Pistone T; Verdière CH; Thiebaut R; Malvy D
    Med Mal Infect; 2008 Oct; 38(10):524-32. PubMed ID: 18715730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Yellow fever vaccination: update on rare and severe adverse effects].
    Receveur MC; Bruyand M; Pistone T; Malvy D
    Med Mal Infect; 2009 Apr; 39(4):234-41. PubMed ID: 19167852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study.
    Roukens AH; Soonawala D; Joosten SA; de Visser AW; Jiang X; Dirksen K; de Gruijter M; van Dissel JT; Bredenbeek PJ; Visser LG
    PLoS One; 2011; 6(12):e27753. PubMed ID: 22163273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptance of yellow fever vaccine in the older traveller: a cohort study.
    Ferrara P; Masuet-Aumatell C; Ramon-Torrell JM
    Acta Biomed; 2021 Sep; 92(4):e2021098. PubMed ID: 34487067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever vaccination status and safety in hemodialysis patients.
    Facincani T; Guimarães MN; De Sousa Dos Santos S
    Int J Infect Dis; 2016 Jul; 48():91-5. PubMed ID: 27208638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yellow fever 17D vaccine safety and immunogenicity in the elderly.
    Monath TP; Cetron MS; McCarthy K; Nichols R; Archambault WT; Weld L; Bedford P
    Hum Vaccin; 2005; 1(5):207-14. PubMed ID: 17012867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yellow fever: the recurring plague.
    Tomori O
    Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Vaccine; 2011 Jun; 29(28):4544-55. PubMed ID: 21549787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow fever vaccine: an effective vaccine for travelers.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study.
    Koehl B; Aupiais C; Schinckel N; Mornand P; Odièvre MH; Niakate A; Brousse V; Ithier G; Missud F; Holvoet L; Benkerrou M; Sorge F; Faye A
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33550421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Severe Yellow fever vaccine-associated disease: a case report and current overview].
    Slesak G; Gabriel M; Domingo C; Schäfer J
    Dtsch Med Wochenschr; 2017 Aug; 142(16):1219-1222. PubMed ID: 28810279
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(44):989-93. PubMed ID: 12455906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late vaccination against yellow fever of travelers visiting endemic countries.
    Krief I; Goldblatt JG; Paz A; Potasman I
    Travel Med Infect Dis; 2006 Mar; 4(2):94-8. PubMed ID: 16887731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National review of reported Yellow fever vaccine incidents in the UK.
    Gnanadurai R; Campos-Matos I; Kanagarajah S; Geary K; Simons H; Patel D
    Travel Med Infect Dis; 2022; 47():102289. PubMed ID: 35227862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal myelitis associated with yellow fever vaccination.
    Chaves M; Riccio P; Patrucco L; Rojas JI; Cristiano E
    J Neurovirol; 2009 Jul; 15(4):348-50. PubMed ID: 19579072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The elderly, the young and the pregnant traveler -- A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination.
    Jaeger VK; Tschudi N; Rüegg R; Hatz C; Bühler S
    Travel Med Infect Dis; 2015; 13(6):475-84. PubMed ID: 26526774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.